Preliminary results of a clinical trial, presented today at the AATS 101st Annual Meeting, showed that a new, low-profile thoracic aortic endograft is safe and effective in the treatment of descending thoracic aortic aneurysm or penetrating atherosclerotic ulcer (PAU) diseases.
Low profile thoracic aortic endograft device reduces complications and expands patient pool
- EurekAlert
- 1. 5 2021 (06:00)